Fig. 2.
Overall survival.
Overall survival is shown from the first IFN-α dose (10-year survival 75%; 95% CI, 66%-84%) or from the date of the first CCgR (10-year survival 72%; 95% CI, 62%-82%). No events have occurred after 120 months, as yet. (a) Number of cases at risk from the first IFN-α dose. (b) Number of cases at risk from the first CCgR.